Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation

Abstract

Systemically sustained thrombin generation in vivo is the hallmark of disseminated intravascular coagulation (DIC). Typically, this is in response to a progressing disease state that is associated with significant cellular injury. The etiology could be infectious or noninfectious, with the main pathophysiological mechanisms involving cross-activation among coagulation, innate immunity, and inflammatory responses. This leads to consumption of both pro- and anticoagulant factors as well as endothelial dysfunction and disrupted homeostasis at the blood vessel wall interface. In addition to the release of tissue plasminogen activator (tPA) and soluble thrombomodulin (sTM) following cellular activation and damage, respectively, there is the release of damage-associated molecular patterns (DAMPs) such as extracellular histones and cell-free DNA. Extracellular histones are increasingly recognized as significantly pathogenic in critical illnesses through direct cell toxicity, the promotion of thrombin generation, and the induction of neutrophil extracellular trap (NET) formation. Clinically, high circulating levels of histones and histone–DNA complexes are associated with multiorgan failure, DIC, and adverse patient outcomes. Their measurements as well as that of other DAMPs and molecular markers of thrombin generation are not yet applicable in the routine diagnostic laboratory. To provide a practical diagnostic tool for acute DIC, a composite scoring system using rapidly available coagulation tests is recommended by the International Society on Thrombosis and Haemostasis. Its usefulness and limitations are discussed alongside the advances and unanswered questions in DIC pathogenesis.

The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score‐matched study

“…This score included laboratory values of platelet counts, prothrombin time, D‐dimer, and fibrinogen. If the total score was 5 or greater, then it was compatible with “overt DIC”; if it was less than 5, then it was suggestive of “non‐overt DIC”; and if it was 0, then it was “not overt DIC.”…”

Cooling therapy upregulates protein C activation in heat stressed rats: An experimental study

“…Plasma sTM levels have been considered to be markers of endothelial cell injury (Toh, Alhamdi, & Abrams, 2016), and were quantified twice after HS. The highest sTM levels were noted in the HS group (p < 0.05).…”

Neutrophils, NETs, NETosis — old or new factors in sepsis and septic shock?

“…Thrombin has anticoagulant properties through thrombomodulin (TM)-dependent protein C activation. Thrombin influences opposite aspects of fibrinolysis as it promotes plasmin generation through stimulating endothelial cells' release of tPA (tissue plasminogen activator) and inhibits fibrinolysis through PAI-1 (plasminogen activator inhibitor 1) induction and TAFI (thrombin-activatable fibrinolysis inhibitor) activity [16]. NETs, because of their histone components, have the capacity to cause bystander injury.…”